Article Versions Notes

Kullenberg F, Degerstedt O, Calitz C, Pavlović N, Balgoma D, Gråsjö J, Sjögren E, Hedeland M, Heindryckx F, Lennernäs H. In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma. Cells. 2021; 10(7):1717. https://doi.org/10.3390/cells10071717

Kullenberg, Fredrik, Oliver Degerstedt, Carlemi Calitz, Nataša Pavlović, David Balgoma, Johan Gråsjö, Erik Sjögren, Mikael Hedeland, Femke Heindryckx, and Hans Lennernäs. 2021. "In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma" Cells 10, no. 7: 1717. https://doi.org/10.3390/cells10071717

Kullenberg, F., Degerstedt, O., Calitz, C., Pavlović, N., Balgoma, D., Gråsjö, J., Sjögren, E., Hedeland, M., Heindryckx, F., & Lennernäs, H. (2021). In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma. Cells, 10(7), 1717. https://doi.org/10.3390/cells10071717